BioLife announces the launch of its first line of cannabinoid consumer products including six new tincture formulations.
Led by a cross functional team of technologists, business leaders, advisors, partners and domain experts, BioLife specializes in moving innovative products from the lab or small scale production into wider market adoption.
BioLife announces the launch of its first line of cannabinoid consumer products including six new tincture formulations.
BioLife Sciences Inc. announced it has successfully received qualification of its Form 1-A with the SEC to raise up to $20,000,000
BioLife announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier 1…
Supported by a deep network of relationships spanning: supply chain, regulatory, product development, R&D, IP, finance, sales & distribution
BioLife works with leading companies to move products from the lab or small scale production into wider market adoption
Supported by a deep network of relationships spanning: supply chain, regulatory, product development, R&D, IP, finance, sales & distribution
Sign Up
BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.
2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United States
Copyright © 2022 BioLife Sciences Inc. All Rights Reserved.
